Global Small Molecule Active Pharmaceutical Ingredient Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Small Molecule Active Pharmaceutical Ingredient by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Small Molecule Active Pharmaceutical Ingredient by Country/Region, 2017, 2022 & 2028

2.2 Small Molecule Active Pharmaceutical Ingredient Segment by Type

2.2.1 Standard API

2.2.2 High Potency API

2.3 Small Molecule Active Pharmaceutical Ingredient Sales by Type

2.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

2.3.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Type (2017-2022)

2.3.3 Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Type (2017-2022)

2.4 Small Molecule Active Pharmaceutical Ingredient Segment by Application

2.4.1 Cardiovascular Diseases

2.4.2 Respiratory Disorders

2.4.3 Infectious Diseases

2.4.4 Others

2.5 Small Molecule Active Pharmaceutical Ingredient Sales by Application

2.5.1 Global Small Molecule Active Pharmaceutical Ingredient Sale Market Share by Application (2017-2022)

2.5.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue and Market Share by Application (2017-2022)

2.5.3 Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Application (2017-2022)

3 Global Small Molecule Active Pharmaceutical Ingredient by Company

3.1 Global Small Molecule Active Pharmaceutical Ingredient Breakdown Data by Company

3.1.1 Global Small Molecule Active Pharmaceutical Ingredient Annual Sales by Company (2020-2022)

3.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2020-2022)

3.2 Global Small Molecule Active Pharmaceutical Ingredient Annual Revenue by Company (2020-2022)

3.2.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Company (2020-2022)

3.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Company (2020-2022)

3.3 Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Company

3.4 Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Location Distribution

3.4.2 Players Small Molecule Active Pharmaceutical Ingredient Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Small Molecule Active Pharmaceutical Ingredient by Geographic Region

4.1 World Historic Small Molecule Active Pharmaceutical Ingredient Market Size by Geographic Region (2017-2022)

4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Annual Revenue by Geographic Region

4.2 World Historic Small Molecule Active Pharmaceutical Ingredient Market Size by Country/Region (2017-2022)

4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Annual Sales by Country/Region (2017-2022)

4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Annual Revenue by Country/Region

4.3 Americas Small Molecule Active Pharmaceutical Ingredient Sales Growth

4.4 APAC Small Molecule Active Pharmaceutical Ingredient Sales Growth

4.5 Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth

4.6 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth

5 Americas

5.1 Americas Small Molecule Active Pharmaceutical Ingredient Sales by Country

5.1.1 Americas Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022)

5.1.2 Americas Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022)

5.2 Americas Small Molecule Active Pharmaceutical Ingredient Sales by Type

5.3 Americas Small Molecule Active Pharmaceutical Ingredient Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Small Molecule Active Pharmaceutical Ingredient Sales by Region

6.1.1 APAC Small Molecule Active Pharmaceutical Ingredient Sales by Region (2017-2022)

6.1.2 APAC Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2017-2022)

6.2 APAC Small Molecule Active Pharmaceutical Ingredient Sales by Type

6.3 APAC Small Molecule Active Pharmaceutical Ingredient Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Small Molecule Active Pharmaceutical Ingredient by Country

7.1.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022)

7.1.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022)

7.2 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Type

7.3 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient by Country

8.1.1 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022)

8.1.2 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022)

8.2 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Type

8.3 Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Small Molecule Active Pharmaceutical Ingredient

10.3 Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient

10.4 Industry Chain Structure of Small Molecule Active Pharmaceutical Ingredient

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Small Molecule Active Pharmaceutical Ingredient Distributors

11.3 Small Molecule Active Pharmaceutical Ingredient Customer

12 World Forecast Review for Small Molecule Active Pharmaceutical Ingredient by Geographic Region

12.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Region

12.1.1 Global Small Molecule Active Pharmaceutical Ingredient Forecast by Region (2023-2028)

12.1.2 Global Small Molecule Active Pharmaceutical Ingredient Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Small Molecule Active Pharmaceutical Ingredient Forecast by Type

12.7 Global Small Molecule Active Pharmaceutical Ingredient Forecast by Application

13 Key Players Analysis

13.1 Johnson Matthey

13.1.1 Johnson Matthey Company Information

13.1.2 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Offered

13.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson Matthey Main Business Overview

13.1.5 Johnson Matthey Latest Developments

13.2 Siegfried Holding AG

13.2.1 Siegfried Holding AG Company Information

13.2.2 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offered

13.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Siegfried Holding AG Main Business Overview

13.2.5 Siegfried Holding AG Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Small Molecule Active Pharmaceutical Ingredient Product Offered

13.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Sanofi S.A.

13.4.1 Sanofi S.A. Company Information

13.4.2 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product Offered

13.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi S.A. Main Business Overview

13.4.5 Sanofi S.A. Latest Developments

13.5 Novartis AG,

13.5.1 Novartis AG, Company Information

13.5.2 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Offered

13.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis AG, Main Business Overview

13.5.5 Novartis AG, Latest Developments

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Company Information

13.6.2 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Offered

13.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb Main Business Overview

13.6.5 Bristol-Myers Squibb Latest Developments

13.7 Boehringer Ingelheim GmbH

13.7.1 Boehringer Ingelheim GmbH Company Information

13.7.2 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Offered

13.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Boehringer Ingelheim GmbH Main Business Overview

13.7.5 Boehringer Ingelheim GmbH Latest Developments

13.8 GlaxoSmithKline

13.8.1 GlaxoSmithKline Company Information

13.8.2 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Offered

13.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GlaxoSmithKline Main Business Overview

13.8.5 GlaxoSmithKline Latest Developments

13.9 Albany Molecular Research Inc.

13.9.1 Albany Molecular Research Inc. Company Information

13.9.2 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

13.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Albany Molecular Research Inc. Main Business Overview

13.9.5 Albany Molecular Research Inc. Latest Developments

13.10 Bachem Holding AG

13.10.1 Bachem Holding AG Company Information

13.10.2 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offered

13.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bachem Holding AG Main Business Overview

13.10.5 Bachem Holding AG Latest Developments

13.11 PCAS

13.11.1 PCAS Company Information

13.11.2 PCAS Small Molecule Active Pharmaceutical Ingredient Product Offered

13.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 PCAS Main Business Overview

13.11.5 PCAS Latest Developments

13.12 Patheon N.V.

13.12.1 Patheon N.V. Company Information

13.12.2 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Product Offered

13.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Patheon N.V. Main Business Overview

13.12.5 Patheon N.V. Latest Developments

13.13 AstraZeneca

13.13.1 AstraZeneca Company Information

13.13.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product Offered

13.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 AstraZeneca Main Business Overview

13.13.5 AstraZeneca Latest Developments

13.14 Johnson & Johnson

13.14.1 Johnson & Johnson Company Information

13.14.2 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product Offered

13.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Johnson & Johnson Main Business Overview

13.14.5 Johnson & Johnson Latest Developments

13.15 Merck & Co

13.15.1 Merck & Co Company Information

13.15.2 Merck & Co Small Molecule Active Pharmaceutical Ingredient Product Offered

13.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Merck & Co Main Business Overview

13.15.5 Merck & Co Latest Developments

13.16 BASF SE

13.16.1 BASF SE Company Information

13.16.2 BASF SE Small Molecule Active Pharmaceutical Ingredient Product Offered

13.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 BASF SE Main Business Overview

13.16.5 BASF SE Latest Developments

13.17 Catalent Inc.

13.17.1 Catalent Inc. Company Information

13.17.2 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

13.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Catalent Inc. Main Business Overview

13.17.5 Catalent Inc. Latest Developments

13.18 Teva Pharmaceuticals

13.18.1 Teva Pharmaceuticals Company Information

13.18.2 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product Offered

13.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Teva Pharmaceuticals Main Business Overview

13.18.5 Teva Pharmaceuticals Latest Developments

13.19 Roche

13.19.1 Roche Company Information

13.19.2 Roche Small Molecule Active Pharmaceutical Ingredient Product Offered

13.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Roche Main Business Overview

13.19.5 Roche Latest Developments

13.20 Cambrex Corporation

13.20.1 Cambrex Corporation Company Information

13.20.2 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product Offered

13.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Cambrex Corporation Main Business Overview

13.20.5 Cambrex Corporation Latest Developments

13.21 GILEAD Science Inc.

13.21.1 GILEAD Science Inc. Company Information

13.21.2 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

13.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 GILEAD Science Inc. Main Business Overview

13.21.5 GILEAD Science Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Small Molecule Active Pharmaceutical Ingredient Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Small Molecule Active Pharmaceutical Ingredient Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Standard API

Table 4. Major Players of High Potency API

Table 5. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (MT)

Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

Table 7. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2017-2022) & ($ million)

Table 8. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2017-2022)

Table 9. Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (MT)

Table 11. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Table 12. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2017-2022)

Table 13. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2017-2022)

Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Small Molecule Active Pharmaceutical Ingredient Sales by Company (2020-2022) & (MT)

Table 16. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Company (2020-2022)

Table 17. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Company (2020-2022)

Table 19. Global Small Molecule Active Pharmaceutical Ingredient Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Producing Area Distribution and Sales Area

Table 21. Players Small Molecule Active Pharmaceutical Ingredient Products Offered

Table 22. Small Molecule Active Pharmaceutical Ingredient Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Small Molecule Active Pharmaceutical Ingredient Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Geographic Region (2017-2022)

Table 27. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country/Region (2017-2022)

Table 31. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (MT)

Table 34. Americas Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2022)

Table 35. Americas Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2022)

Table 37. Americas Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (MT)

Table 38. Americas Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

Table 39. Americas Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (MT)

Table 40. Americas Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Table 41. APAC Small Molecule Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (MT)

Table 42. APAC Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)

Table 43. APAC Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2017-2022)

Table 45. APAC Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (MT)

Table 46. APAC Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

Table 47. APAC Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (MT)

Table 48. APAC Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Table 49. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (MT)

Table 50. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2022)

Table 51. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2022)

Table 53. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (MT)

Table 54. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

Table 55. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (MT)

Table 56. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Small Molecule Active Pharmaceutical Ingredient

Table 66. Key Market Challenges & Risks of Small Molecule Active Pharmaceutical Ingredient

Table 67. Key Industry Trends of Small Molecule Active Pharmaceutical Ingredient

Table 68. Small Molecule Active Pharmaceutical Ingredient Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Small Molecule Active Pharmaceutical Ingredient Distributors List

Table 71. Small Molecule Active Pharmaceutical Ingredient Customer List

Table 72. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Forecast by Region

Table 74. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2023-2028)

Table 92. Johnson Matthey Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 93. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 94. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Johnson Matthey Main Business

Table 96. Johnson Matthey Latest Developments

Table 97. Siegfried Holding AG Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 98. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 99. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Siegfried Holding AG Main Business

Table 101. Siegfried Holding AG Latest Developments

Table 102. Pfizer Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 104. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Pfizer Main Business

Table 106. Pfizer Latest Developments

Table 107. Sanofi S.A. Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 108. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 109. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Sanofi S.A. Main Business

Table 111. Sanofi S.A. Latest Developments

Table 112. Novartis AG, Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 113. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 114. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Novartis AG, Main Business

Table 116. Novartis AG, Latest Developments

Table 117. Bristol-Myers Squibb Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 118. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 119. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Bristol-Myers Squibb Main Business

Table 121. Bristol-Myers Squibb Latest Developments

Table 122. Boehringer Ingelheim GmbH Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 123. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 124. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Boehringer Ingelheim GmbH Main Business

Table 126. Boehringer Ingelheim GmbH Latest Developments

Table 127. GlaxoSmithKline Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 128. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 129. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. GlaxoSmithKline Main Business

Table 131. GlaxoSmithKline Latest Developments

Table 132. Albany Molecular Research Inc. Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 133. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 134. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Albany Molecular Research Inc. Main Business

Table 136. Albany Molecular Research Inc. Latest Developments

Table 137. Bachem Holding AG Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 138. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 139. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Bachem Holding AG Main Business

Table 141. Bachem Holding AG Latest Developments

Table 142. PCAS Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 143. PCAS Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 144. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. PCAS Main Business

Table 146. PCAS Latest Developments

Table 147. Patheon N.V. Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 148. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 149. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. Patheon N.V. Main Business

Table 151. Patheon N.V. Latest Developments

Table 152. AstraZeneca Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 153. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 154. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 155. AstraZeneca Main Business

Table 156. AstraZeneca Latest Developments

Table 157. Johnson & Johnson Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 158. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 159. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 160. Johnson & Johnson Main Business

Table 161. Johnson & Johnson Latest Developments

Table 162. Merck & Co Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 163. Merck & Co Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 164. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 165. Merck & Co Main Business

Table 166. Merck & Co Latest Developments

Table 167. BASF SE Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 168. BASF SE Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 169. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 170. BASF SE Main Business

Table 171. BASF SE Latest Developments

Table 172. Catalent Inc. Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 173. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 174. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 175. Catalent Inc. Main Business

Table 176. Catalent Inc. Latest Developments

Table 177. Teva Pharmaceuticals Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 178. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 179. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 180. Teva Pharmaceuticals Main Business

Table 181. Teva Pharmaceuticals Latest Developments

Table 182. Roche Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 183. Roche Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 184. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 185. Roche Main Business

Table 186. Roche Latest Developments

Table 187. Cambrex Corporation Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 188. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 189. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 190. Cambrex Corporation Main Business

Table 191. Cambrex Corporation Latest Developments

Table 192. GILEAD Science Inc. Basic Information, Small Molecule Active Pharmaceutical Ingredient Manufacturing Base, Sales Area and Its Competitors

Table 193. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Product Offered

Table 194. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 195. GILEAD Science Inc. Main Business

Table 196. GILEAD Science Inc. Latest Developments

List of Figures

Figure 1. Picture of Small Molecule Active Pharmaceutical Ingredient

Figure 2. Small Molecule Active Pharmaceutical Ingredient Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Small Molecule Active Pharmaceutical Ingredient Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Standard API

Figure 10. Product Picture of High Potency API

Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2021

Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2017-2022)

Figure 13. Small Molecule Active Pharmaceutical Ingredient Consumed in Cardiovascular Diseases

Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Market: Cardiovascular Diseases (2017-2022) & (MT)

Figure 15. Small Molecule Active Pharmaceutical Ingredient Consumed in Respiratory Disorders

Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Market: Respiratory Disorders (2017-2022) & (MT)

Figure 17. Small Molecule Active Pharmaceutical Ingredient Consumed in Infectious Diseases

Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Market: Infectious Diseases (2017-2022) & (MT)

Figure 19. Small Molecule Active Pharmaceutical Ingredient Consumed in Others

Figure 20. Global Small Molecule Active Pharmaceutical Ingredient Market: Others (2017-2022) & (MT)

Figure 21. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)

Figure 22. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application in 2021

Figure 23. Small Molecule Active Pharmaceutical Ingredient Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Company in 2021

Figure 25. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Geographic Region in 2021

Figure 27. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)

Figure 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country/Region in 2021

Figure 29. Americas Small Molecule Active Pharmaceutical Ingredient Sales 2017-2022 (MT)

Figure 30. Americas Small Molecule Active Pharmaceutical Ingredient Revenue 2017-2022 ($ Millions)

Figure 31. APAC Small Molecule Active Pharmaceutical Ingredient Sales 2017-2022 (MT)

Figure 32. APAC Small Molecule Active Pharmaceutical Ingredient Revenue 2017-2022 ($ Millions)

Figure 33. Europe Small Molecule Active Pharmaceutical Ingredient Sales 2017-2022 (MT)

Figure 34. Europe Small Molecule Active Pharmaceutical Ingredient Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales 2017-2022 (MT)

Figure 36. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue 2017-2022 ($ Millions)

Figure 37. Americas Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2021

Figure 38. Americas Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2021

Figure 39. United States Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2021

Figure 44. APAC Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2021

Figure 45. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2021

Figure 52. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2021

Figure 53. Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2021

Figure 60. Egypt Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Small Molecule Active Pharmaceutical Ingredient Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Small Molecule Active Pharmaceutical Ingredient in 2021

Figure 66. Manufacturing Process Analysis of Small Molecule Active Pharmaceutical Ingredient

Figure 67. Industry Chain Structure of Small Molecule Active Pharmaceutical Ingredient

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles